ALG3 and breast carcinoma: Previous work by Sun et al. demonstrated that ALG3 could activate TGFβ signaling by mediating N-glycosylation modification of TGFBR2-β, ultimately promoting radioresistance and stem cell characteristics in breast cancer 41.